SE7514388L - Forfarande for att forbettra gammaglobuliners introvenostolerans - Google Patents

Forfarande for att forbettra gammaglobuliners introvenostolerans

Info

Publication number
SE7514388L
SE7514388L SE7514388A SE7514388A SE7514388L SE 7514388 L SE7514388 L SE 7514388L SE 7514388 A SE7514388 A SE 7514388A SE 7514388 A SE7514388 A SE 7514388A SE 7514388 L SE7514388 L SE 7514388L
Authority
SE
Sweden
Prior art keywords
gamma globulin
solution
centrifuged
precipitated
hydroxyethyl starch
Prior art date
Application number
SE7514388A
Other languages
Unknown language ( )
English (en)
Other versions
SE437470B (sv
Inventor
W Schneider
D Wolter
Original Assignee
Ratiopharma Anstalt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ratiopharma Anstalt filed Critical Ratiopharma Anstalt
Publication of SE7514388L publication Critical patent/SE7514388L/sv
Publication of SE437470B publication Critical patent/SE437470B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE7514388A 1975-01-02 1975-12-18 Forfarande for utvinning av ett rent gammaglobulinpreparat, som tolereras vid intravenos administrering SE437470B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2500076A DE2500076C3 (de) 1975-01-02 1975-01-02 Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen

Publications (2)

Publication Number Publication Date
SE7514388L true SE7514388L (sv) 1976-07-05
SE437470B SE437470B (sv) 1985-03-04

Family

ID=5935911

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7514388A SE437470B (sv) 1975-01-02 1975-12-18 Forfarande for utvinning av ett rent gammaglobulinpreparat, som tolereras vid intravenos administrering

Country Status (20)

Country Link
JP (1) JPS5512001B2 (sv)
AT (1) AT344883B (sv)
AU (1) AU505416B2 (sv)
BE (1) BE837211A (sv)
CA (1) CA1058075A (sv)
DD (1) DD121875A5 (sv)
DE (1) DE2500076C3 (sv)
DK (1) DK144679C (sv)
EG (1) EG11987A (sv)
ES (1) ES443982A1 (sv)
FR (1) FR2296429A1 (sv)
GB (1) GB1495159A (sv)
IE (1) IE43449B1 (sv)
IL (1) IL48766A (sv)
IN (1) IN143525B (sv)
NL (1) NL179824C (sv)
PL (1) PL99599B1 (sv)
SE (1) SE437470B (sv)
SU (1) SU576898A3 (sv)
ZA (1) ZA758050B (sv)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2604759C2 (de) * 1976-02-07 1983-06-01 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von iv-verträglichen Γglobulinen
JPS6016406B2 (ja) * 1976-08-06 1985-04-25 マイヤ−、ル−イス、コ−バル 静脈内に投与可能なガンマ・グロブリンの製造法ならびにそれにより調製したガンマ・グロブリン
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
GB1603244A (en) * 1977-05-20 1981-11-18 Max Planck Gesellschaft Medicaments for the suppression of pathological processes
JPS5822085B2 (ja) * 1977-07-19 1983-05-06 株式会社ミドリ十字 静注用ガンマ・グロブリン製剤
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
EP0019403B1 (en) * 1979-05-10 1985-07-31 American Hospital Supply Corporation Hydroxyalkyl-starch drug carrier
US4396608A (en) * 1981-08-24 1983-08-02 Cutter Laboratories Intravenously injectable immune serum globulin
EP0085747B2 (de) * 1982-02-08 1990-05-30 Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten Intravenös verabreichbares humanes Immunglobulin und Verfahren zu dessen Herstellung
US4482483A (en) * 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
SE8302483L (sv) * 1983-05-02 1984-11-03 Pharmacia Ind Forfarande vid rening av biologiskt aktiva substanser
US5945098A (en) * 1990-02-01 1999-08-31 Baxter International Inc. Stable intravenously-administrable immune globulin preparation
DE19907257A1 (de) * 1999-02-21 2000-09-14 Bernd Horst Meier Mittel zur Steuerung der Diffusion von Injektionslösungen
DE10040707A1 (de) * 2000-08-17 2002-03-14 Braun Melsungen Ag Kolloidale Pharmakomodulation injizierter Arzneimittel
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
PT2289909E (pt) 2005-11-30 2015-02-10 Abbvie Inc Método de rastreio, processo de purificação de globulómeros a-beta não difundíveis, anticorpos selectivos contra os referidos globulómeros a-beta não difundíveis e processo para o fabrico dos referidos anticorpos
KR20140087058A (ko) 2005-11-30 2014-07-08 애브비 인코포레이티드 아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
US20100311767A1 (en) 2007-02-27 2010-12-09 Abbott Gmbh & Co. Kg Method for the treatment of amyloidoses
ES2684475T3 (es) 2010-04-15 2018-10-03 Abbvie Inc. Proteínas que se unen a beta amiloide
MX358739B (es) 2010-08-14 2018-09-03 Abbvie Inc Star Proteinas de union a amiloide beta.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (sv) * 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
DE2234069A1 (de) * 1971-07-16 1973-02-08 South African Inventions Verfahren zur herstellung eines gereinigten gamma-globulins
IL43643A (en) * 1972-11-27 1976-10-31 Baxter Laboratories Inc Method for production of gamma globulin
JPS49101516A (sv) * 1973-01-13 1974-09-25

Also Published As

Publication number Publication date
JPS5191321A (en) 1976-08-10
IE43449B1 (en) 1981-02-25
ATA981675A (de) 1977-12-15
DE2500076C3 (de) 1982-11-18
IL48766A0 (en) 1976-02-29
IN143525B (sv) 1977-12-17
EG11987A (en) 1981-12-31
NL7514627A (nl) 1976-07-06
DK144679C (da) 1982-10-11
AU505416B2 (en) 1979-11-22
ES443982A1 (es) 1977-07-16
IE43449L (en) 1976-07-02
DD121875A5 (sv) 1976-09-05
ZA758050B (en) 1976-12-29
BE837211A (fr) 1976-06-30
SU576898A3 (ru) 1977-10-15
IL48766A (en) 1979-11-30
CA1058075A (en) 1979-07-10
GB1495159A (en) 1977-12-14
FR2296429B1 (sv) 1978-12-01
AT344883B (de) 1978-08-10
NL179824C (nl) 1986-11-17
DK584375A (da) 1976-07-03
DK144679B (da) 1982-05-10
SE437470B (sv) 1985-03-04
JPS5512001B2 (en) 1980-03-29
DE2500076A1 (de) 1976-07-08
PL99599B1 (pl) 1978-07-31
FR2296429A1 (fr) 1976-07-30
DE2500076B2 (de) 1979-02-22
AU8792175A (en) 1977-07-14
NL179824B (nl) 1986-06-16

Similar Documents

Publication Publication Date Title
SE7514388L (sv) Forfarande for att forbettra gammaglobuliners introvenostolerans
ES462065A1 (es) Procedimiento para la preparacion de derivados de tiazolidi-na.
ES8506758A1 (es) Un procedimiento para preparar un compuesto de oclusion de 2-nitroximetil-6-cloropiridina
FI844557L (fi) Koncentrat av antihemofilfaktorn viii och foerfarande foer framstaellning av detsamma.
EP0096007A3 (en) Pharmaceutical preparation containing (+)-cyanidan-3-ol derivatives, the use thereof, novel substituted (+)-cyanidan-3-ol derivatives, and processes for producing them
GB1480700A (en) Rifamycin s and sv derivatives
GB1386150A (en) 6-acylaminophenyl-4,5-dihydropyridazones
GB779493A (en) Process for the isolation of stable, highly purified gamma globulin preparations
GB1312391A (en) Basically substituted 4 3h- quinazolinone derivatives and process for their manufacture
GB1475314A (en) Phenyl-propylamine derivatives
GB1443692A (en) 1,2-diphenylethanolamine derivatives and their salts and the preparation thereof
ATE59144T1 (de) Verfahren zur herstellung von gamma-globulin zur intravenoesen anwendung.
GB1243953A (en) Benzdiazepine derivatives
GB1377596A (en) Process for the preparation of 1-substituted 3-hydroxypyrazoles
GB1423992A (en) Photosensitive material of biological origin
ATA439276A (de) Verfahren zur herstellung von 18-arabinosyl-2-n-butyl-3,7,11,15,19,21,23,25,27,37-dekahydroxy-4,16,32,34,36-pentamethyl-tetrakonta-16,32-dien-35-o-lacton-40-guanidiniumsulfat(debrycin) enthaltenden pharmazeutischen praparaten
ATE73818T1 (de) Verfahren zur herstellung von peptiden unter der verwendung von perchloraten.
IE34609L (en) Therapeutic substituted thiazolidinedione
Lewis et al. Erythropoietic Activity in Human Urine Concentrate.
GB1312392A (en) Basically substituted 4 3h-quinazolinone derivatives and process for their manufacture
DE2311333C2 (de) Verfahren zur Herstellung eines intravenös injizierbaren modifizierten Immunserumglobulins
NO864382D0 (no) Midler for forbedring av proteinabsorpsjon.
GB1384684A (en) 1,3,5-triazine and process for the preparation thereof
GB1290468A (sv)
GB1472937A (en) Benzyl alcohol derivatives

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7514388-3

Effective date: 19891128

Format of ref document f/p: F